文献速递皮肤感染药疹与重症皮肤不良反应

并非所有皮疹都是COVID-19:伴SARS-CoV-2感染的皮肤表现需组织病理学检查的病例系列

Not all that glitters is COVID-19: a case series demonstrating the need for histopathology when skin findings accompany SARS-CoV-2 infection.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2021-06-07

最常见COVID-19相关模式为发疹性表现,4例出现离散丘疹的新模式。结论强调在将皮肤表现归因于COVID-19前,组织病理学检查至关重要。

要点

  • 最常见COVID-19相关皮肤模式为发疹性表现,未发现冻疮样病变。
  • 4例出现离散丘疹新模式,组织病理学表现多样,包括1例中性粒细胞性小汗腺炎。

核心结论

  • 在将皮肤表现归因于COVID-19之前,组织病理学检查至关重要。

研究设计与样本

  • 纳入连续确诊COVID-19且请求皮肤科会诊的住院患者,所有病例均行皮肤活检。

主要发现

  • 最常见COVID-19相关模式为发疹性表现。
  • 4例观察到离散丘疹的新模式,组织病理学表现多样,包括1例中性粒细胞性小汗腺炎。
  • 未发现冻疮样病变。
  • 与COVID-19无关的诊断包括马拉色菌毛囊炎、癣、痱子和接触性皮炎。

关键数值与推荐

  • 皮肤表现分类为符合COVID-19皮肤表现或代表独立临床实体。
  • 与COVID-19无关的皮肤诊断占29%。

临床怎么用

  • 对伴SARS-CoV-2感染的皮肤表现,应进行皮肤活检以明确诊断。
  • 避免仅凭临床外观将皮肤表现归因于COVID-19。

局限性

  • 尚无金标准试验区分病毒性皮疹与药物反应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Descriptions of cutaneous findings associated with COVID-19 have not been consistently accompanied by histopathology or confirmatory testing for SARS-CoV-2. OBJECTIVE: To describe and classify the cutaneous findings with supporting histopathology of confirmed COVID-19 inpatients. METHODS: We included consecutive inpatients with a confirmed diagnosis of COVID-19 for whom a dermatology consult was requested. A skin biopsy was performed in all cases. Skin findings were classified as being compatible with a cutaneous manifestation of COVID-19 or as representing a distinct clinical entity. RESULTS: Twenty-eight patients were studied in whom thirty-one dermatologic diagnoses were made. Twenty-two of the dermatoses were compatible with a cutaneous manifestation of COVID-19; nine entities were not associated with infection by SARS-CoV-2. The most common COVID-19-associated pattern was an exanthematous presentation. In four patients, a new pattern was observed, characterized by discrete papules with varied histopathological findings including a case of neutrophilic eccrine hidradenitis. No cases of pernio-like lesions were identified. Skin findings not associated with COVID-19 represented 29% of diagnoses and included Malassezia folliculitis, tinea, miliaria and contact dermatitis. LIMITATIONS: There is no gold-standard test to distinguish between viral exanthems and drug reactions. CONCLUSION: A histopathological study is critical before attributing skin findings to a manifestation of COVID-19.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Barrera-Godínez A, Méndez-Flores S, Gatica-Torres M, et al. Not all that glitters is COVID-19: a case series demonstrating the need for histopathology when skin findings accompany SARS-CoV-2 infection. J Eur Acad Dermatol Venereol. 2021. PMID: 34013600. doi:10.1111/jdv.17381

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。